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Background: Rats showing spontaneous atopic dermatitis (AD)-like skin lesions were 
observed in the Kyoto fancy rat stock 4 (KFRS4) strain breeding colony. 
Objective: To establish the KFRS4 rat as a model of AD. 
Methods: The clinical symptoms of AD-like skin lesions were assessed by scoring the 
degree of dermatitis and examining scratching behavior. The transepidermal water loss 
was measured to evaluate skin barrier function. Cells infiltrating the skin lesions were 
identified using histological and immunohistological analyses. IgE and cytokine levels 
were measured to examine immune status. An ointment treatment experiment was 
carried out to characterize dermatitis in the KFRS4 rats. 
Results: Dermatitis initially appeared around 4 months of age and rapidly worsened 
from 6 to 8 months of age. The skin lesions accompanied scratching behavior and were 
predominantly observed in females. The increased transepidermal water loss indicated 
skin barrier dysfunction. Extensive infiltration of eosinophils, mast cells and 
lymphocytes was observed in the skin lesions. The plasma IgE level increased in accord 
with increasing severity of dermatitis. The Th2 and Th17 cytokine mRNA levels were 





non-skin-draining lymph nodes. It was demonstrated that betamethasone improved the 
symptoms of dermatitis. These findings demonstrated that dermatitis in the KFRS4 rats 
closely resembled that seen in human AD. 
Conclusion: Female KFRS4 rats have the potential to serve as an animal model of 
human AD. 
 







AD, atopic dermatitis 
HE, hematoxylin-eosin 
KFRS4, Kyoto fancy rat stock 4 
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Atopic dermatitis (AD) is a relapsing chronic inflammatory skin disease 
characterized by eczematous skin lesions and intense pruritus [1]. AD affects at least 
15% of children and 2–10% of adults in industrialized countries, and there is growing 
evidence of an increase in prevalence [2]. AD is often associated with elevated serum 
immunoglobulin E (IgE) levels and a personal or family history of type I allergies, 
allergic rhinitis and asthma.  
The etiology of AD is highly complex, but several lines of evidence suggest 
that a genetic predisposition leads to a defective skin barrier and a dysregulated immune 
response [3, 4]. Environmental triggers such as food allergens, inhalable respiratory 
allergens, irritating substances and infectious microorganisms [5, 6] play an important 
role in the development of AD. Scratching induced by pruritus disrupts skin barrier 
functions, which also contributes to the development of AD [7]. Thus, skin barrier 
function, immunology, pruritus and the environment, as well as interactions among 
these factors, are important considerations when examining the mechanisms underlying 
the development of AD. 





procedures for diagnosis, prevention and treatment, animal models of AD are essential. 
These models allow the in-depth investigation of pathogenesis and provide invaluable 
tools for diagnostic and pharmaceutical purposes. There are various mouse models of 
AD available, including models induced by epicutaneous sensitization, genetically 
engineered models and spontaneous models [8]. Among them, NC/Nga mice have been 
a widely used AD-like dermatitis model with an elevation in IgE levels and intense 
pruritus; this is primarily influenced by mite infection in specific pathogen free (SPF) 
conditions [9, 10]. Although mouse models are primarily used, rat models of AD are 
also expected to be developed because rats are widely used in biomedical and 
pharmaceutical research areas.  
Kyoto Fancy Rat Stock 4 (KFRS4) rats have been developed from hybrids 
between the fancy rat and PVG/Seac inbred strain rats [11]. During inbreeding, several 
mutant phenotypes carried by the fancy rat are selected. As such, KFRS4 rats carry 
mutations that include bright coat color, hooded coat pattern, white spotting on the head 
and cataracts [12-15].  
In the present study, we newly observed spontaneous dermatitis that 





months of age and worsened progressively during the next 2 months. It seemed that 
there was a sex difference in incidence; almost all female rats but only some males were 
affected. To characterize KFRS4 rats as a model of AD, we examined the clinical 
symptoms, scratching behavior, histological analysis of skin lesions and immune status. 
In addition, we performed a treatment experiment regarding dermatitis on the KFRS4 





2. Materials and Methods 
2.1. Rats 
KFRS4/Kyo (NBRP#0572) and PVG/Seac (NBRP#0080) rat strains were 
sourced from the National BioResource Project-Rat, Kyoto University (Kyoto, Japan). 
Rats were bred in conventional conditions in which they were free of mites but were 
infected by pinworms (Syphacia muris). All animal experiments were approved by the 
Animal Research Committee of Kyoto University and were conducted according to the 
Regulations on Animal Experimentation of Kyoto University. 
2.2. Reagents 
Mouse anti-rat CD4 (clone, W3/25; 1:5000) and mouse anti-rat CD8 alpha 
(clone, OX-8; 1:500) were purchased from AbD Serotec (Raleigh, North Carolina, 
USA). Heparinoid cream (Hirudoid® Soft) and betamethasone dipropionate 
(Rinderon®-V Ointment 0.12%) were purchased from Maruho Co., Ltd. (Osaka, Japan) 





2.3. Clinical observation 
The clinical severity of the skin lesions was scored in male (n = 8) and female 
(n = 8) KFRS4 rats according to the macroscopic diagnostic criteria, termed the total 
skin lesion severity score (TSLSS) [16]. Briefly, the TSLSS was designated as the sum 
of the individual scores, graded as 0 (none), 1 (mild), 2 (moderate) and 3 (severe) for 
the symptoms of erythema, eczema, crust, edema and erosion in six regions of the body, 
namely the face, head and neck, forelegs, hind legs, dorsal and ventral regions of the 
trunk.  
2.4. Histology 
For histological analysis, major organs including the skin were harvested, fixed 
in buffered 10% formalin, embedded in paraffin and stained with hematoxylin-eosin 
(HE) [17]. For examination of mast cells, skin sections were stained with toluidine blue 
(TB). The number of mast cells was calculated as the average from 20 fields of 
dermatitis (n = 4) and normal (n = 4) skin samples (original magnification, ×400). For 
immunohistochemistry, 10-μm frozen sections of the skin from 6-month-old KFRS4 





Sections were treated with 10% goat serum in PBS and then incubated for 1 h at room 
temperature with anti-CD4 and CD8 antibodies. After incubation with the primary 
antibodies, sections were treated with peroxidase-conjugated secondary antibody 
(Histofine Simplestain MAX-PO: Nichirei, Tokyo, Japan) and signals were visualized 
using a DAB substrate kit (Nichirei).  
2.5. Measurement of plasma IgE 
Rats were anesthetized with isoflurane and blood samples were collected from 
the tail tip using heparinized hematocrit tubes. Total plasma IgE levels were measured 
using a rat IgE EIA kit (Takara Bio Inc., Otsu, Shiga, Japan).  
2.6. Skin barrier function 
The dorsal region of the skin was shaved in female KFRS4 (n = 6) and PVG (n 
= 6) rats before measurement. To evaluate the inside-to-outside barrier function, 
transepidermal water loss (TEWL) was measured using a Tewameter Vapo Scan (Asahi 
Biomed, Tokyo, Japan) at 24°C and 46% relative humidity at 5 and 9 weeks of age. 





2.7. Scratching behavior 
Pruritus was evaluated in terms of the level of scratching behavior. Rats aged 4 
months (n = 6), 6 months (n = 6) and 8 months (n = 6) were placed individually in 
plastic cages (30 cm × 30 cm × 20 cm). After an acclimation period (60 min), the 
number of scratching movements was counted in the morning during the 60-min 
observation period.  
2.8. Treatment of dermatitis 
Four-month-old female KFRS4 rats (n = 18) were divided into three groups. 
Group 1 rats were untreated (n = 6), group 2 rats were treated with heparinoid cream (n 
= 6) and group 3 rats were treated with betamethasone (n = 6). Ointment was applied to 
the skin of the head and neck three times per week. Every 4 weeks, the clinical 
observation of the skin, an examination of scratching behavior and measurement of 
plasma IgE were performed. At 7 months of age, animals were sacrificed under 
isoflurane anesthesia and the spleen, adrenal glands, lymph nodes (LNs) and skin were 





2.9. Quantitative real-time polymerase chain reaction 
Thirteen skin-draining LNs and 8 non skin-draining LNs (mesenteric and renal) 
were harvested from 3 KFRS4 rats. Messenger RNA (mRNA) was isolated using 
ISOGEN II (Nippon Gene Co., Ltd, Tokyo, Japan) according to the manufacturer’s 
instructions. Real-time polymerase chain reaction was performed using the Thermal 
Cycler Dice Real Time System (Takara Bio Inc., Otsu, Shiga, Japan) with SYBR 
Premix Ex Taq II (Takara Bio Inc.). By monitoring the amplification curves of a test 
sample and reference samples that contained 101 to 106 molecules of the gene of interest, 
the number of target molecules in the test sample was analyzed. The number of target 
molecules was normalized to that of peptidylprolyl isomerase A (Ppia) as an internal 
control [18]. The primers used are listed in Supplementary Table 1. 
2.10. Hinkelmann staining 
Peripheral blood samples were collected from the tail veins of 
dermatitis-affected (6–8 months of age; n = 7) and non-affected (4–5 months of age; n = 
6) female KFRS4 rats. Blood samples (10 μL) were stained with Hinkelmann’s solution 





2.11. Statistical analysis 
Data were analyzed using an unpaired two-tailed t-test. P values < 0.05 were 






3.1. Spontaneous dermatitis in KFRS4 rats 
Skin lesions initially appeared as erythema on the lips or forelegs at around 4 
months of age. Until 6 months of age, mild skin lesions consisting of erythema, eczema, 
and crust were seen on the skin of the KFRS4 rats. With increasing age, severe edema 
and erosion were seen, particularly in the skin of the head and neck region and the 
dorsal region of the trunk (Fig. 1A). These skin lesions were observed in 100% of 
8-month-old female and 50% of 8-month-old male KFRS4 rats examined. TSLSS was 
significantly higher in females than in the age-matched males (Fig. 1B). The frequency 
of scratching behavior during the 60-min observation period dramatically increased 
after 6 months of age in female KFRS4 rats (Fig. 1C). In contrast, no skin lesions or 
scratching behavior were observed in PVG rats, a parental strain of KFRS4.  
3.2. Skin barrier function in KFRS4 rats 
Because skin barrier dysfunction is a common characteristic of AD [7, 19], we 





rats was significantly higher than that of PVG rats both at 5 and 9 weeks of age (Fig. 
1D) when no dermatitis was observed clinically and histologically. This finding 
indicates a defect in the skin barrier function of KFRS4 rats before the appearance of 
dermatitis. 
3.3. Histological examination of skin lesions in female KFRS4 rats 
The histology of early skin lesions in KFRS4 rats showed epidermal 
hyperplasia with mild spongiosis, parakeratosis, and infiltration of lymphocytes in the 
epidermis and superficial dermis (Fig. 2A). As the lesions progressed, there was 
extensive infiltration of eosinophils and lymphocytes in the dermis. A skin ulcer that 
was covered by crusts formed by fibrin exudate and necrotic tissue debris was often 
observed (Fig. 2B). In addition, mast cells that were detected using TB staining 
increased in number in the dermis of dermatitis-affected skin as compared with 
non-dermatitis skin (Fig. 2C). The infiltration of both CD4+ and CD8+ T cells was 
observed in the dermatitis-affected skin (Fig. 2D). The number of CD4+ cells was 
significantly increased in the dermatitis region as compared with the non-dermatitis 





significantly increased (18.2 ± 4.68 vs 0.50 ± 0.53; P < 0.01; Fig. 2D). None of these 
changes were observed in PVG rats. 
3.4. Immune status of KFRS4 rats in the steady state 
To elucidate the immune status of female KFRS4 rats, we measured the levels 
of total IgE, because the increased severity of AD is reported to be correlated with 
elevated IgE levels [16, 20]. IgE levels were significantly higher in female KFRS4 rats 
than in age-matched male KFRS4 rats from the onset (5 months of age) to the 
exacerbation phase of dermatitis (7 months of age) (Fig. 3A). To examine the immune 
status of KFRS4 rats showing severe dermatitis, we measured the Th1 (interferon 
(IFN)-γ), Th2 (interleukin (IL)-4), Th17 (IL-17A, IL-22 and IL-23), and Treg (IL-10), 
plasma cell (tumor necrosis factor [TNF]α) cytokine mRNA levels of the skin-draining 
mandibular and axillary LNs of the affected rats, and compared them with those of the 
non-skin-draining LNs. The mRNA levels of IL-22, IL-23, IL-4 and TNFα were 
significantly higher in the skin-draining LNs than in the non-skin-draining LNs (Fig. 
3B). Furthermore, we examined the number and proportion of eosinophils in the 





eosinophils has been found in most patients with AD and correlates with disease activity 
[21]. Eosinophils increased significantly in number in dermatitis-affected KFRS4 rats as 
compared with non-affected rats (Fig. 3C). The proportion of eosinophils in leukocytes 
was also significantly increased (2.7 ± 1.1% in non-affected rats vs 12.4 ± 4.0% in 
dermatitis-affected rats; P < 0.01).  
These findings suggest that Th2, Th17 cells and eosinophils, similar to those in 
human AD patients [22], play an important role in the pathogenesis of dermatitis in 
KFRS4 rats.  
3.5. Suppression of dermatitis by steroids 
Because topical steroid treatment is commonly used for AD, we carried out 
ointment treatment experiments in female KFRS4 rats. Heparinoid cream was used as a 
control. When compared with untreated and heparinoid-treated rats, the rats treated with 
betamethasone ointment showed a significant improvement in TSLSS (Fig. 4A) and 
scratching behavior (Fig. 4B). The IgE level in betamethasone-treated rats tended to be 
lower than in non-treated or heparinoid-treated rats, but was not significantly different 





Histological examination showed that marked skin inflammation and ulceration 
were evident in the non-treated or heparinoid cream-treated rats but were virtually 
absent in the betamethasone-treated rats (Fig. 4C). These findings indicate that 
betamethasone is effective in treating dermatitis in KFRS4 rats, which is also observed 






KFRS4 rats showed spontaneous dermatitis that accompanied scratching 
behavior, elevation of plasma IgE, and Th2 and Th17 cytokine mRNAs. The histology 
of the skin lesion was characterized by the infiltration of lymphocytes, eosinophils and 
mast cells. The increased TEWL indicated skin barrier dysfunction in KFRS4 rats. In 
addition, the treatment with betamethasone ointment had marked effects on suppression 
of dermatitis. These clinical, immunological and histological features of KFRS4 rat 
dermatitis closely resemble those seen in human AD. Thus, KFRS4 rats are considered 
to be a good model of AD.  
The microbiological environments where animals are bred play important roles 
in the development of dermatitis. NC/Nga mice develop dermatitis when bred in 
conventional conditions or under specific pathogen free conditions with an infection of 
house dust mites [9]. Staphylococcus aureus colonization on the skin drives 
inflammation in spontaneous or genetically modified rodent models of AD [23, 24]. 
KFRS4 rats are bred without mites but with infection by pinworms (Syphacia muris), 
which are known to influence allergic reactions in mice [25]. Thus, pinworms may be 





immune system or the generation of allergens. The development of pinworm-free 
KFRS4 rats in specific pathogen free conditions would be required to address the 
microbiological environment issue. 
Although no sex differences have been observed in human AD patients [26, 27] 
or mouse models of AD [9, 16, 28], we found a clear sex difference in the dermatitis of 
KFRS4 rats. Female KFRS4 rats developed much more severe dermatitis as compared 
with age-matched males. Because male and female KFRS4 rats are kept in identical 
environments, female sex apparently predisposes KFRS4 rats to AD-like skin lesions. 
There are sex differences in immune responses, especially from the perspective of 
collagen vascular diseases, and the immune response plays a pivotal role in the 
development of AD [7, 29, 30]. Thus, it is possible to consider that the sex difference 
may influence the development of AD in certain conditions. The sex difference in the 
immune response is attributed not only to differences in sex hormones, such as estrogen, 
testosterone and progesterone, but also to X chromosome gene contributions [30]. The 
X chromosome gene contributions would appear as X-linked diseases in which males 
show the severe phenotype and females are relatively unaffected. Thus, it is likely that 





KFRS4 rats. To this end, developing ovariectomy or orchiectomy in KFRS4 rats would 
be needed. 
We carried out an ointment treatment experiment in KFRS4 rats and found that 
steroid (betamethasone) was effective in suppressing dermatitis. This finding suggested 
that KFRS4 rats are suitable for the evaluation of new drugs or treatments for AD. 
Owing to 100% prevalence of dermatitis, female KFRS4 rats could be considered as 
providing an efficient bioassay system. Indeed, in KFRS4 rats, skin barrier dysfunction 
occurred before the appearance of dermatitis. Daily application of moisturizer during 
the neonatal period reduces the risk of AD [31]. Thus, it would be interesting to 
examine the preventive effect of moisturizer on dermatitis in KFRS4 rats before the 
appearance of dermatitis. 
In summary, KFRS4 rats spontaneously developed dermatitis that accompanied 
an elevation of IgE and scratching behavior. The dermatitis was evidently suppressed by 
topical application of betamethasone. In addition, increased TEWL was observed before 
the onset of dermatitis, which indicates that there was skin barrier dysfunction in 
KFRS4 rats. Taken together, KFRS4 rats have the potential to serve as an animal model 
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Fig. 1. Spontaneous dermatitis in Kyoto Fancy Rat Stock 4 rats. (A) Clinical 
photographs of 5-, 6- and 7-month-old Kyoto Fancy Rat Stock 4 (KFRS4) rats. (B) 
Total skin lesion severity scores (TSLSS) for male and female KFRS4 rats. Females 
showed significantly higher scores than age-matched males after 6 months of age. (C) 
Scratching behavior of female KFRS4 rats. (D) Total epidermal water loss (TEWL) 
through the dorsal skin of 5- and 8-week-old female PVG and KFRS4 rats. *: P < 0.05; 
**: P < 0.01. 
Fig. 2. Histological observations of the skin lesions of KFRS4 rats. (A, B) 
HE-stained sections of the dermatitis region in 7-month-old KFRS4 rats. In the 
eczematous lesions (A; original magnification ×200), epidermal hyperplasia with mild 
spongiosis and infiltration of lymphocytes in the epidermis and superficial dermis were 
observed. In the progressed lesion (B; original magnification ×40), severe infiltrations 
of lymphocytes and eosinophils (inset; original magnification ×400) in the dermis and 





(left, original ×400) and the number of mast cells per field under 400-fold magnification 
(right). (D) Immunohistochemical staining of CD4 and CD8 in the skin of 6-month-old 
KFRS4 rats. Both CD4+ and CD8+ lymphocytes (arrows) were observed in the skin 
lesions but not in the normal skin of KFRS4 rats (left, original magnification ×400). The 
number of CD4+ and CD8+ cells per field under 400-fold magnification (right). **: P < 
0.01. 
Fig. 3. Immunological status of KFRS4 rats. (A) Total plasma IgE levels in male 
(open) and female (closed) KFRS4 rats. Females showed significantly higher IgE levels 
than age-matched males. (B) Expression levels of cytokines in the lymph nodes (LNs) 
of the dermatitis-affected female KFRS4 rats. (C) Number of eosinophils in the 
peripheral blood of the dermatitis-affected and non-affected KFRS4 rats. *: P < 0.05; 
**: P < 0.01. 
Fig. 4. Effects of ointments on dermatitis in KFRS4 rats. (A) TSLSS of 
ointment-treated and non-treated KFRS4 rats (left) and clinical photographs of 





greatly suppressed the dermatitis. (B) Scratching behavior in ointment-treated and 
non-treated KFRS4 rats. (C) HE-stained sections of the skin on which ointment was 







TK and TS designed the research. MY, DT, AY, AN, YH and KY performed the 
experiments. MT, MK and HH performed the pathological examination. TK, HH and 








































































































































































































































































Supplementary Table 1 Primers used in the study
Symbol Gene name GenBank acc Forward Forward start Reverse Reverse start Product size
Ifng interferon gamma NM_138880.2 AGGCCATCAGCAACAACATAAGTG 266 GACAGCTTTGTGCTGGATCTGTG 405 140
Il10 interleukin 10 NM_012854.2 CAGACCCACATGCTCCGAGA 110 CAAGGCTTGGCAACCCAAGTA 250 141
Il17a interleukin 17A NM_001106897.1 CTGATCAGGACGAGCGACCA 40 ACTGTAGCCTCCAGGTTCAGTAGCA 126 87
Il22 interleukin 22 NM_001191988.1 GATGCTCTGCCCATCAACTCC 94 CCCGATGAGCCTGACATCTG 228 135
Il23a Interleukin 23, alpha subunit p19 NM_130410.2 TCCCGGAATCTCTGCACACT 416 CAGACCTTGGCGGATCCTT 601 186
Il4 interleukin 4 NM_201270.1 TGCACCGAGATGTTTGTACCAGA 169 TTGCGAAGCACCCTGGAAG 260 92
Ppia peptidylprolyl isomerase A (cyclophilin ANM_017101.1 GGCAAATGCTGGACCAAACAC 342 AAACGCTCCATGGCTTCCAC 476 135
Tnf tumor necrosis factor NM_012675.2 AACTCGAGTGACAAGCCCGTAG 400 GTACCACCAGTTGGTTGTCTTTGA 532 133
